According to AstraZeneca's latest financial reports the company's total debt is $28.62 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $28.62 B | -2.09% |
2022-12-31 | $29.23 B | -5.03% |
2021-12-31 | $30.78 B | 51.04% |
2020-12-31 | $20.38 B | 11.81% |
2019-12-31 | $18.22 B | -4.64% |
2018-12-31 | $19.11 B | 7.33% |
2017-12-31 | $17.80 B | 5.94% |
2016-12-31 | $16.80 B | 11.66% |
2015-12-31 | $15.05 B | 38.83% |
2014-12-31 | $10.84 B | 4.5% |
2013-12-31 | $10.37 B | 0.64% |
2012-12-31 | $10.31 B | 10.53% |
2011-12-31 | $9.32 B | 1.15% |
2010-12-31 | $9.22 B | -16.64% |
2009-12-31 | $11.06 B | 868.74% |
2008-12-31 | $1.14 B | -92.47% |
2007-12-31 | $15.15 B | 1139.25% |
2006-12-31 | $1.22 B | 1.83% |
2005-12-31 | $1.20 B | -5.36% |
2004-12-31 | $1.26 B | 178.9% |
2003-12-31 | $0.45 B | -46.09% |
2002-12-31 | $0.84 B | -11.72% |
2001-12-31 | $0.95 B |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $29.33 B | 2.48% | ๐บ๐ธ USA |
Novartis NVS | $26.34 B | -7.94% | ๐จ๐ญ Switzerland |
Pfizer PFE | $70.84 B | 147.52% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $15.62 B | -45.40% | ๐บ๐ธ USA |
Eli Lilly LLY | $25.22 B | -11.87% | ๐บ๐ธ USA |
Sanofi SNY | $20.36 B | -28.84% | ๐ซ๐ท France |
Biogen BIIB | $7.33 B | -74.36% | ๐บ๐ธ USA |
Merck MRK | $35.05 B | 22.48% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $41.46 B | 44.87% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $22.93 B | -19.86% | ๐ฌ๐ง UK |